The last 4C states they will be meeting with the FDA in quater 2 of 24 exploring tge accelerated approval pathway for a phase 2 trial starting second half of this year.
I am thinking these are the next real catalysts for PTX. I could be wrong and they announce a bunch of CRs from the phase 1b, but maybe not : )
So i think the share price will bob along until we get something that will be seen as reducing risk to the market.
Cash wise, the 4c says that as of 31st Dec they had over 6 quarters of money in the bank. SYC comments that he should be able to do better than that withbthe funds available. So that should get that Phase 2 trial a long way down the road before more cash is needed. So hopefully that will happen at a higher price.
Its a tough market at the moment. But that means there is lots of opportunity for those that can wait.
PTX Price at posting:
5.1¢ Sentiment: Buy Disclosure: Held
